entertainment -WSS

entertainment

author：Wikipedia 2025-10-01 02:27:22 - browse：1

Maze Therapeutics CEO Jason Coloma Courtesy

After seeing its last deal go bust in the face of regulatory scrutiny, Maze Therapeutics has found another suitor for its experimental Pompe disease treatment.

Bay Area-based Maze and Shionogi said Friday that the Japanese pharma company had licensed the drug, called MZE001, with an upfront payment of $150 million. The global deal includes additional, undisclosed payments if the oral medication, which is in clinical testing, meets certain regulatory and commercial goals.

Last year, Sanofi, the French pharma giant, was set to pay $150 million in cash and stock to Maze before the transaction fell apart.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Following judge's order, DOJ releases slightly less

WSS

3 protesters arrested at Wimbledon after interrupting matches by throwing confetti on court

2 million sign

EU moves toward latest gene techniques in food production to counter climate change, shortages

Supreme Court shows surprising restraint in chaotic year of crises: ANALYSIS

Princess Kate attends Wimbledon with Roger Federer: See the photos

Princess Kate attends Wimbledon with Roger Federer: See the photos

hotspot

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

explore

The high cost of giving birth even with insurance

NIH confirmation hearing shows politicization of research

In Memoriam: Notable people who died in 2023

FDA warns J&J's Abiomed: We will regulate your software

New air purifier tech could be key to improving indoor air quality

Dramatic video released of Russian fighter jets 'harassing' US drones over Syria

George Santos makes 1st court appearance after pleading not guilty to 13 counts

STAT Readout Newsletter: Today's biggest biotech updates

Anesthesiologist group: stop taking Ozempic before surgery

Condition critical? Britain's beloved but battered National Health Service turns 75

explore

1 in 4 Americans hadn't contracted COVID by the end of 2022, CDC estimates

3 protesters arrested at Wimbledon after interrupting matches by throwing confetti on court

Man pleads guilty to raping Ohio girl who ended up traveling across state lines for abortion

Senate committee scrutinizes Medicare Advantage brokers

Biden's Plan B on student loan forgiveness relies on Higher Education Act: What to know

Former New York Mayor de Blasio and wife announce separation, but not divorce

entertainment

knowledge

entertainment

leisure time